Tepilta® Versus Oxetacaine, Antacids and Placebo
Clinical trial NCT01336530 · TERMINATED
Trial details
- NCT number
- NCT01336530
- Sponsor
- MEDA Pharma GmbH & Co. KG
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2017-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.